References
- Nair AG, Patil-Chhablani P, Venkatramani DV, Gandhi RA. Ocular myasthenia gravis: A review. Indian J Ophthalmol. 2014;62 (10):985-91. https://doi.org/10.4103/0301-4738.145987
- Hendricks TM, Bhatti MT, Hodge DO, Chen JJ. Incidence, Epidemiology, and Transformation of Ocular Myasthenia Gravis: A Population-Based Study. American Journal of Ophthalmology. 2019;205:99-105. https://doi.org/10.1016/j.ajo.2019.04.017
- David G, Norman B, Tatsuji N, Murali P. Lifetime course of myasthenia gravis. Muscle & Nerve. 2008;37(2):141-9. https://doi.org/10.1002/mus.20950
- Association of Korean Medicine Professors for Cardiovasuclar and Neurological Medicine. Cardiovascular and Neurological Medicine in Korean Medicine. Seoul: Wooripub. 2016:285-90
- Hong JH, Park JW, Kim JS, Jeon WH, Cho NH, Oh SW, et al. A Case of Myasthenia Gravis with Thymoma. The Journal of Korean Oriental Chronic Disease. 2000;6(1):27-32.
- Choi SW, Song BY. A Clinical Case Study on the Effects of Bojungikgitang and Pharmacopuncture in Myasthenia Gravis Patient. Journal of Rare and Incurable Diseases. 2017;1(1):29-32.
- Bae YC, Park SJ. A Case Study on the Alleviation of Symptom of a Myasthenia Gravis Patient after Korean Medicine Treatment. J. Int. Korean Med. 2019; 40(1):136-44. https://doi.org/10.22246/jikm.2019.40.1.136
- Vincent A, McConville J, Farrugia ME, Newsom-Davis J. Seronegative myasthenia gravis. Semin Neurol. 2004;24:125-33. https://doi.org/10.1055/s-2004-829589
- Howard JF Jr, Sanders DB, Massey JM. The electrodiagnosis of myasthenia gravis and the Lambert-Eaton myasthenic syndrome. Neurol Clin. 1994;12(2):305-30. https://doi.org/10.1016/s0733-8619(18)30099-9
- Mao ZF, Mo XA, Qin C, Lai YR, Hackett ML. Incidence of thymoma in myasthenia gravis: a systematic review. J Clin Neurol. 2012;8(3):161-9. https://doi.org/10.3988/jcn.2012.8.3.161
- Juel VC, Massey JM. Myasthenia gravis. Orphanet J Rare Dis. 2007;2:44 https://doi.org/10.1186/1750-1172-2-44
- Narayanaswami P, Sanders DB, Wolfe G, Benatar M, Cea G, Evoli A, et al. International Consensus Guidance for Management of Myasthenia Gravis: 2020 Update. Neurology. 2020[cited 2020 Nov 3]. Availabe from:URL:https://n.neurology.org/content/early/2020/11/03/WNL.0000000000011124
- Meridians & Acupoints Compilation Committee of Korean Oriental Medical Colleges. Acupuncture Points (VolumeI). Seoul:Jeongdam. 2020:58-9, 69-70, 137-8, 153-7, 246-8, 475-6, 494-5.
- Meridians & Acupoints Compilation Committee of Korean Oriental Medical Colleges. Acupuncture Points (VolumeII). Seoul:Jeongdam. 2020:208, 226 273-4 280-1, 407, 614-5, 629-30, 651-2.
- Lee JD, Kang SG, Lee YH, Go HG, Lee SG, Park DS. The Study on the Hominis Placenta Aqua-acupuncture Solution. The Journal of Korean Acupuncture and Moxibustion Society. 2000;17(1):67-74.
- Zhang WT, Jin Z, Cui GH, Zhang KL, Zhang L, Zeng YW, et al. Relations between brain network activation and analgesic effect induced by low vs. high frequency electrical acupoint stimulation in different subjects: a functional magnetic resonance imaging study. Brain Research. 2003;982(2):168-78. https://doi.org/10.1016/S0006-8993(03)02983-4
- Pascuzzi RM, Coslett HB, Johns TR. Long-term corticosteroid treatment of myasthenia gravis: Report of 116 patients. Ann Neurol. 1984;15(3):291-8. https://doi.org/10.1002/ana.410150316
- Shi B, Zeng L. Management of myasthenia gravis during pregnancy: A report of eight cases. Open Life Sciences. 2018;13(1): 28-33. https://doi.org/10.1515/biol-2018-0004